An Intelligent Platform for Personalized Remote Monitoring of the Cardiac Patients with Electronic Implant Devices http://www.srdc.com.tr/icardea/ - PowerPoint PPT Presentation

About This Presentation
Title:

An Intelligent Platform for Personalized Remote Monitoring of the Cardiac Patients with Electronic Implant Devices http://www.srdc.com.tr/icardea/

Description:

An Intelligent Platform for Personalized Remote Monitoring of the Cardiac Patients with ... (ICD) Cardiac Resynchronization Therapy (CRT) Implantable Loop ... – PowerPoint PPT presentation

Number of Views:219
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: An Intelligent Platform for Personalized Remote Monitoring of the Cardiac Patients with Electronic Implant Devices http://www.srdc.com.tr/icardea/


1
An Intelligent Platform for Personalized Remote
Monitoring of the Cardiac Patients with
Electronic Implant Devices http//www.srdc.com.tr
/icardea/
  • Catherine Chronaki
  • On behalf of SRDC and the iCardea Consortium

Credit J. Brugada
2
Causes of death in heart failure
3
Cardiac Implantable Electronic Devices
  • Pacemaker (PM)
  • Implantable Cardioverter-Defibrillator (ICD)
  • Cardiac Resynchronization Therapy (CRT)
  • Implantable Loop recorder (ILR)
  • Implantable Hemodynamic Monitoring (IHM()

4
Cardiac Implantable Electronic Devices
  • Pacemaker (PM)
  • Implantable Cardioverter-Defibrillator (ICD)
  • Cardiac Resynchronization Therapy (CRT)
  • Implantable Loop recorder (ILR)
  • Implantable Hemodynamic Monitoring (IHM()

5
The number of cardiac implants in increasing..
  • Expected exponential increase over the next years
  • 2 million patients worldwide
  • 2007

Pacemakers ICDs CRTs
North America 564.074 234780 148092
Europe 683472 87747 61010
6
Telemonitoring technology in the EU
7
Device Telemonitoring opportunities
8
Device Telemonitoring opportunities
9
Management from home-ICD opportunities
10
Device-Centric Diagnostics
11
Status of Affairs in interoperability
12
iCardea Objectives
  • There has been an exponential growth in the
    number of cardiac implantable devices 800.000
    CIED patients in EU with 5.8 million follow-up
    visits
  • CIED electronic and software complexity have
    widen their function and application
  • However, due to their limited processing
    capabilities restricted by their size, CIEDs need
    to be supported with software running on the data
    centers
  • Currently, the data center processing is
    standalone with their custom software and
    proprietary interfaces
  • Patient and device data is stored in data centres
    operated by the vendors
  • Presented via secure Web-sites to the access of
    responsible healthcare professionals
  • Access to follow-up information often requires
    clinicians to use multiple vendor specific
    systems and interfaces, reducing efficiency

13
CIED Data Exposure Module
  • iCARDEA aims to expose CIED data through standard
    interfaces based
  • International standards such as HL7, ISO/IEEE
    11073 (Point of Care Medical Device Communication
    Standards)
  • Standard profiles such as Integrating the
    Healthcare Enterprise (IHE) Implantable Device
    Cardiac Observations (IDCO) Profile
  • Standard transport protocols such as Web Services
  • iCARDEA will provide the necessary
    authentication, authorization and secure transfer
    of data mechanisms based on solid standards and
    profiles
  • As a result...
  • CIED data will be ready to be integrated into the
    automated clinical follow-up workflows
  • By exposing CIED data through standard
    interfaces, interoperability of data coming from
    CIEDs from different vendors will be made
    achievable

14
Personalized Adaptive Care Planner for CIED
Recipients
  • Personalized follow-up of CIED patients will be
    coordinated through a care plan
  • An executable definition of a care pathway that
    consists of computer interpretable clinical
    guideline models
  • Control flow of the care plan will be dynamically
    adapted based on the patients context
  • Personalized Adaptive Care Planner Engine
  • Care plan will be constructed through re-usable
    building blocks to be personalized for each
    patient
  • Subscribe to necessary context variables provided
    by the data source services
  • Interact with the existing healthcare
    institutions for operations like scheduling
    in-clinic follow-up with the responsible
    physician
  • Check the existing healthcare records from EHR
    systems
  • Provide reminder and personalized guidance
    services to the patient to enable improved
    compliance with the follow-up

14
15
Interoperability Infrastructure for EHRs, PHRs
and Code Systems
  • Follow-up of CIED patients requires access to
    medical history and other clinical information of
    the patients that are stored in EHR and PHR
    systems
  • iCARDEA will develop Interoperability
    Infrastructure for EHRs
  • Enable the legacy EHR systems of the end-users
    (in whatever format they are) to expose EHR using
    HL7 CDA as the EHR content standard and HL7 Web
    Services Profile as the transport protocol
    standard
  • Interoperability Infrastructure for Personal
    Health Records
  • IHE Exchange of Personal Health Record Content
    (XPHR) Profile will be implemented in iCARDEA
  • Code Mapping API
  • Handle automatic mapping of coded terms from
    different code systems by implementing HL7 Common
    Terminology Services (CTS) interfaces
  • Unified Medical Language System Knowledge Source
    Server (UMLSKS)
  • The implementation will be exposed as Web
    Services as defined by the CTS

16
Data Analysis and Correlation Tool
  • For detection of further complications such as
    contraindications and co-morbidities
  • Analogical reasoning will be used
  • Analyze patients various physiological
    parameters such as blood pressure, pulse and
    electrocardiogram (ECG) gathered via CIED Data
    Exposure Module together with the patient data
    extracted from electronic healthcare records or
    patient health records
  • Correlate the data with the data stored in
    established biomedical knowledge bases, such as
    PhysioNET, to extract hidden patterns and trends
    in data which leverages the quality and
    effectiveness of decision making and to alert
    doctors in an unusual situation or unexpected
    profile deviations

17
Patient Empowerment Framework
  • iCARDEA will provide a Web based Personal Health
    Record (PHR) system
  • Patients will be able to view their medical
    history, CIED data, and manage their medication
    summaries, daily nutrition information
  • iCARDEA targets high acceptance of patients and
    gain the maximum clinical and social benefit
  • Tools for patient education and feedback will be
    provided
  • Static and dynamic educative materials such as
    written guidelines and interactive demos
  • Facilitate connection with the responsible
    healthcare professional for enabling patients to
    send and retrieve feedback about their health
    status
  • Patient controlled and configurable privacy
    mechanisms and enhanced security mechanisms will
    be provided
  • Privacy will be managed by the patient himself
    through the Patient Consent Editor

17
18
iCARDEA Architecture
18
19
iCARDEA Pilot Application
  • Deployment will be in Salzburg Clinics in Austria
    with two groups of patients
  • First group of ICD patients with ordinary
    post-surgical control (twice per year),
  • Second group of ICD patients with
    iCARDEA-enhanced remote monitoring, each group
    between 20-50 persons
  • The aspects of evaluation and validation will
    include
  • Possible medical risks which could be detected
    earlier
  • Management of symptoms
  • Time and pathway from patient symptoms to
    clinical decision in response to the symptom
  • Indicators on how remote iCARDEA monitoring can
    reduce risks for the patients (concerning the
    device and medical risks)
  • Usability and acceptance (patients, medical
    experts)
  • Patient well-being
  • Current barriers and limits perspectives for
    future developments
  • Adequacy of the iCARDEA security and privacy
    measures

20
iCardea Data Sources
  • Cardiovascular Implantable Electronic Devices
  • Pace Maker
  • Implantable cardioverter defibrillators (ICD)
  • Cardiac Resynchronization Therapy (CRT) device
  • EHR
  • Previous or ongoing healthcare problems
  • Medications
  • Family History
  • PHR
  • Dietary
  • Daily usage of medications
  • Allergies
  • Physical Activities

21
Example Data to be used in Decision Support
  • History of non-cardiac conditions
  • Detailed information about severity of each
    condition (e.g., specifics of therapy for the
    condition)
  • The medications
  • The non-cardiac conditions denoting
    contraindications to the proposed therapies

22
An Example the Prognosis of Heart Failure
  • Predictors come from different sources
  • From EHR and PHR
  • Demographics
  • Body Weight, Physical Activity
  • The medications (including angiotensin-converting
    enzyme inhibitors and beta-blockers)
  • Problems Hypotension, Diabetes, Anaemia, Chronic
    obstructive pulmonary disease, Depression, Sleep
    related breathing disorders
  • From CIED
  • Electrophysiological Tachycardia, Complex
    Ventricular Arrhythmias, Atrial Fibrillation,
    Heart Rate Variability
  • The onset of atrial fibrillation has also shown
    to be a predictor sudden cardiac death
  • An increase in mean heart rate has been shown to
    predict an increase in cardiac mortality
  • Accumulation of consecutive day-to-day
    differences between the daily and reference
    impedance can predict heart failure

23
Foreseen Decision Making Processes
  • An Example
  • A patient with ischemic cardiomyopathy is
    discharged with a ICD implantation
  • Data followed diagnostic data on heart rhythm,
    atrial, and ventricular arrhythmias accompanied
    by IECG (VT, VF, SVF Detection, Ventricular
    Episodes, Mode Switch episode duration,
    Ventricular Rhythm, Mean Ventricular Rate, Mean
    Ventricular Extrasistole, CRT Pacing )
  • From this data, atrial and ventricular arrhythmia
    development is detected (Early detection of
    Asymptomatic clinical event)
  • Combining this data with data coming from the
    patients EHR and PHR, the following becomes
    possible
  • Change in drug therapy by considering
  • Comorbidities
  • Intolerances to certain drugs
  • Current medications

24
iCARDEA consortium
Partner no Partner name Partner org. short name
EHR-profiles Software Research and Development and Consultancy Ltd. SRDC, Turkey
Research OFFIS e.V. (OFFIS) OFFIS, Germany
Research Salzburg Research Forschungsgesellschaft m.b.H SRFG, Austria
interoperability Foundation for Research and Technology Hellas Institute of Computer Science FORTH, Greece
Hospital Salzburger Landeskliniken BetriebsgesmbH SALK, Austria
ICD manufacturer St. Jude Medical Medizintechnik Ges.m.b.H SJM, Austria
ICD manufacturer Medtronic Österreich GmbH Medtronic, Austria
hospital Hospital Clinic I Provincial de Barcelona HCPB, Spain
25
iCARDEA Architecture
25
26
Thank very much you for your attention
  • http//www.srdc.com.tr/icardea/
Write a Comment
User Comments (0)
About PowerShow.com